Analysis of risk factors in readmission patients with coronary heart disease

doi:10.3969/j.issn.1004-583X.2016.06.013

Clinical Focus

Previous Articles Next Articles

Analysis of risk factors in readmission patients with coronary heart disease

Department of Cardiology， Tianjin Institute of Cardiology， the Second Hospital of Tianjin Medical University，
Tianjin Key Laboratory of IonicMolecular Function of Cardiovascular Disease， Tianjin 300211， China

Received:2016-02-17 Online:2016-06-05 Published:2016-06-06
Contact: Corresponding author: Li Guangping， Email: tjcardiol@tijmu.edu.cn

Abstract

Abstract:

ObjectiveTo analyze the risk factors in readmitted patients with coronary heart disease， intending to strength the preventive and therapeutic strategy to reduce the readmission ratio of highrisk population. MethodsA total of 115 readmitted patients with CHD were selected as the experiment group， on the contrary， 78 initial patients with CHD were statistically analyzed as the control group. The relationship between readmission and clinical indicators were explored. ResultsThe valnes in age，high blood pressure，T2DM， AMI， cardiac function NYHA ⅢⅣ， LAD， LVEDD， IVS and LVPW were significantly higher in experiment group than in control group， however， LVEF was significantly lower in experiment group than in control group (P<0.05). Multivariable logistic regression analysis showed that age， hypertension， LAD， and LVEF were associated with readmission (P<0.05). ConclusionStrengthening the intervention and devoting special attention on patients with high blood pressure and diabetes， elderly ages and the related complications， taking measures to improve heart function will have substantial benefits on preventing the readmission in patients with CHD.

Key words: coronary heart disease, patient readmission, risk factors

Fan Chong， Li Guangping. Analysis of risk factors in readmission patients with coronary heart disease[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2016.06.013.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.06.013

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I6/641

[1]	Yu Zeyu, Lin Xi, Chen Zhanghua, Yang Wei, Chen Zhimin, Zhang Hai. Analysis of risk factors for refractory Mycoplasma pneumoniae pneumonia in children [J]. Clinical Focus, 2024, 39(1): 43-46.
[2]	Liu Lili, Yuan Yuting, Lai Gengliang, Tian Chuan, Lan Xiang, Ye Zhonglv. The relationship between minimal residual disease on day 15 and prognosis in children with acute lymphoblastic leukemia [J]. Clinical Focus, 2024, 39(1): 47-52.
[3]	Wei Zeng, Cao Ling, She Dunmin, Liu Yan, Wang Yan, Zhang Zhenwen. The causes of death in 54 patients with type 2 diabetes mellitus complicated with COVID-19 [J]. Clinical Focus, 2023, 38(9): 806-812.
[4]	Wang Yingnan, Zhao Qi, Bai Haiwei, Wu Danna, Wei Jinmei, Li Shengjiang, Li Ruiling, Zhang Ruixing. Clinical characteristics and risk factors of gastric cancer-related stroke [J]. Clinical Focus, 2023, 38(5): 417-422.
[5]	Ma Mingfu, Wei Zhiguo, He Tieying. Meta-analysis of risk factors for pancreatic pseudocyst in acute pancreatitis [J]. Clinical Focus, 2023, 38(4): 293-301.
[6]	Leng Wantong, Tao Jie. Risk factors of postoperative venous thromboembolism in patients with multiple myeloma [J]. Clinical Focus, 2023, 38(4): 340-345.
[7]	Ma Hongli, Lu Hao, Wang Dan, Jiao Haixing, Li Yike, Li Siyu, Lu Jing. Meta-analysis of disability risk factors in stroke patients [J]. Clinical Focus, 2023, 38(2): 111-116.
[8]	Du Jiayi, Liu Lili, He Yongzhong, Tian Chuan, Lan Xiang, Ye Zhonglyu. Clinical observation of serious adverse events in children with acute lymphoblastic leukemia during chemotherapy [J]. Clinical Focus, 2023, 38(2): 149-154.
[9]	Liang Bingsong, Li Yuying, Zhang Qiping, Chen Yingdao, Li jian. Analysis of factors affecting clinical efficacy of Tirofiban in treating branch atheromatous disease [J]. Clinical Focus, 2023, 38(12): 1091-1094.
[10]	Shi Peihua, Lin Yanlin, Bi Lifang. Study on the correlation of NLR, PLR and MLR with type 2 diabetes mellitus complicated with coronary heart disease [J]. Clinical Focus, 2023, 38(11): 996-1001.
[11]	Ding Siqi, Liu Shihua, Zhang Chao, Zhong Ping, Cao Li. Risk factors for epilepsy after delayed post-stroke epilepsy and its clinical correlation with blood Hcy, hs-CRP and D-D [J]. Clinical Focus, 2023, 38(10): 893-897.
[12]	Yao Huajun, Zhou Jun, Yin Xue, Zhang Haie, Zhang Haiyan. Analysis on congenital cytomegalovirus infection rate and risk factors of high viral load of high-risk newborns in Xiaogan City Single Center [J]. Clinical Focus, 2022, 37(6): 530-533.
[13]	Li Ya, Qiu Shixiang, Chen Chao, Zhong Liming. Depression-related factors and corresponding correlations with quality of life in patients with hepatocellular carcinoma [J]. Clinical Focus, 2022, 37(6): 539-543.
[14]	Song Siping, Jiang Qixia, Liu Xiaoqing. Risk factors of intraoperative acquired pressure injury: A systematic review and meta-analysis [J]. Clinical Focus, 2022, 37(3): 211-219.
[15]	Zheng Lihua, Du Runsen, Zhao Yaheng, Liu Peng. Influencing factors and predictive indicators of vascular calcification [J]. Clinical Focus, 2022, 37(2): 114-118.

Analysis of risk factors in readmission patients with coronary heart disease

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments